Phase I of HIV Prevention Vaccine Clinical Trials Looks Promising
November 7, 2012 8:05 PM
comment(s) - last by
Over the course of Phase I, patients have not experienced negative effects while taking SAV001-H
for prevention has had a successful Phase I Clinical Trials in the United States, and is preparing to move on to Phase II and Phase III.
The preventative HIV vaccine (called SAV001-H) was developed by Dr. Chil-Yong Kang and a team of researchers at the University of Western Ontario's Schulich School of Medicine & Dentistry as well as researchers from Sumagen Co. Ltd. Unlike other HIV vaccines that underwent clinical trials, SAV001-H contains a killed whole HIV-1 rather than just one specific part of HIV as an antigen or genetic vaccine using recombinant DNA.
Phase I of clinical trials for the first HIV preventative vaccine started in March 2012.
Infected men and women
ranging from 18-50 years of age were separated into two groups, where one received SAV001-H and the other a placebo.
Over the course of Phase I, patients have not experienced negative effects while taking SAV001-H. This includes signs/symptoms, laboratory toxicities and local reactions.
"We have proven that there is no safety concern of SAV001-H in human administration and we are now prepared to take the next steps towards Phase II and Phase III clinical trials," said Dr. Dong Joon Kim, spokesperson for Sumagen. "We are delighted to be one step closer to the first commercialized HIV vaccine."
Also, interim data showed a large increase in HIV-1 antibody formations after SAV001-H was given to patients.
The humoral immune responses still need to be analyzed, but these initial results are promising. This could make SAV001-H the first commercially available HIV prevention vaccine in the United States at some point.
There has been great progress for preventative HIV drugs in the U.S. lately. Back in July, the U.S. Food and Drug Administration (FDA) approved the
HIV prevention pill called "Truvada."
University of Western Ontario
This article is over a month old, voting and posting comments is disabled
RE: I Already Have My HIV Prevention Vaccine
11/10/2012 2:39:45 PM
Not to mention that HIV-1M has been calculated to have been around since at least the early 1900's, and an estimated 3 million people or so around the world are affected by it annually. It's sad that I can tell when my fellow American's post by their ethnocentrism. Hey self-indulged children, guess what? The world is bigger and more important than just you.
"Game reviewers fought each other to write the most glowing coverage possible for the powerhouse Sony, MS systems. Reviewers flipped coins to see who would review the Nintendo Wii. The losers got stuck with the job." -- Andy Marken
New Sensor Allows Naked Eye to See Early Detection Test Results for Diseases
October 30, 2012, 7:20 PM
New Polymer "PEI" Strengthens Vaccines Against HIV/Herpes/Flu
August 28, 2012, 10:45 AM
FDA Approves HIV Prevention Pill "Truvada"
July 16, 2012, 11:01 PM
Creationists are Mad About Google Doodle Depicting Evolution
November 24, 2015, 8:48 PM
DHS and TSA: Whoops, We Missed That 73 Airport Employees May be Terrorists
November 19, 2015, 2:16 PM
Star Wars Spinoff Film "Rogue One", Theme Park Attractions Announced
August 17, 2015, 12:20 PM
SpaceX Falcon 9's Seventh Supply Mission to ISS Ends w/ Fiery Stage 1 Explosion
June 28, 2015, 1:10 PM
Cool Science Video: Glowing Millipede Prowls the Nevada Desert
May 18, 2015, 12:00 PM
Newly Discovered Costa Rican Glass Frog is Kermit's Doppelgänger
April 22, 2015, 11:26 AM
Latest Blog Posts
Sceptre Airs 27", 120 Hz. 1080p Monitor/HDTV w/ 5 ms Response Time for $220
Dec 3, 2014, 10:32 PM
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
More Blog Posts
Copyright 2016 DailyTech LLC. -
Terms, Conditions & Privacy Information